The U.S. Food and Drug Administration (FDA) yesterday approved the expanded use of Rexulti (brexpipr...
Although irritability and anger attacks are relatively common in patients with major depressive diso...
New findings from a phase 3 clinical trial, published today in AJP in Advance, suggest that a recent...
